Compare ATAI & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATAI | PNTG |
|---|---|---|
| Founded | 2018 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.0B |
| IPO Year | 2025 | 2019 |
| Metric | ATAI | PNTG |
|---|---|---|
| Price | $4.18 | $31.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | $15.88 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 6.6M | 189.2K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | N/A | ★ 0.84 |
| Revenue | $4,089,000.00 | ★ $947,705,000.00 |
| Revenue This Year | N/A | $24.72 |
| Revenue Next Year | N/A | $7.61 |
| P/E Ratio | ★ N/A | $36.43 |
| Revenue Growth | ★ 1227.60 | 36.31 |
| 52 Week Low | $1.29 | $21.74 |
| 52 Week High | $6.73 | $35.25 |
| Indicator | ATAI | PNTG |
|---|---|---|
| Relative Strength Index (RSI) | 51.59 | 54.04 |
| Support Level | $4.05 | $27.88 |
| Resistance Level | $4.30 | $31.86 |
| Average True Range (ATR) | 0.35 | 1.11 |
| MACD | -0.02 | 0.16 |
| Stochastic Oscillator | 31.36 | 90.83 |
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.